Nams Stock Analysis Newamsterdam Pharma 0.55 Pct Daily Gain 32.99 Price Outlook 20260403 1 CRK Q1 2026 Earnings Earnings Miss Expectations Amid Challenging Natural Gas Environment RDVT Q1 2026 Earnings Earnings Beat Estimates by Over 40 Stock Rises RARE Q1 2026 Earnings WiderthanExpected Loss as Pipeline Development Continues TWAV Q3 2022 Earnings Deep Loss Exceeds Expectations Stock Drops 76 FIZZ Q1 2026 Earnings EPS Falls Slightly Short Amid Cost Headwinds Vertex Inc VERX Q1 2026 Earnings EPS Beat Drives Modest Share Gains Revenue Unreported